Browsing Family Medicine by UP Author "Ahmed, Khatija"

Browsing Family Medicine by UP Author "Ahmed, Khatija"

Sort by: Order: Results:

  • Clinical outcomes of intrauterine device insertions by newly trained providers : the ECHO trial experience 
    Yacobson, Irina; Wanga, Valentine; Ahmed, Khatija; Chipato, Tsungai; Gichangi, Peter; Kiarie, James; Louw, Cheryl; Morrison, Susan; Moss, Margaret; Mugo, Nelly R.; Palanee-Phillips, Thesla; Pleaner, Melanie; Scoville, Caitlin W.; Thomas, Katherine K.; Nanda, Kavita; for the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium (Elsevier, 2023)
    OBJECTIVES : To assess the rates of failed insertion, expulsion, and perforation when intrauterine device (IUD) insertions were done by newly trained clinicians, and to examine factors that may affect these outcomes. STUDY ...
  • High levels of pretreatment HIV-1 drug resistance mutations among South African women who acquired HIV during a prospective study 
    Beesham, Ivana; Parikh, Urvi M.; Mellors, John W.; Davey, Dvora L. Joseph; Heffron, Renee; Palanee-Phillips, Thesla; Bosman, Shannon L.; Beksinska, Mags; Smit, Jennifer; Ahmed, Khatija; Makkan, Heeran; Selepe, Pearl; Louw, Cheryl; Kotze, Philip; Hofmeyr, G. Justus; Singata-Madliki, Mandisa; Rees, Helen; Baeten, Jared M.; Wallis, Carole (Lippincott Williams and Wilkins, 2022-10)
    BACKGROUND : Pretreatment HIV drug resistance (PDR) undermines individual treatment success and threatens the achievement of UNAIDS 95-95-95 targets. In many African countries, limited data are available on PDR as detection ...
  • Quantifiable plasma tenofovir among South African women using daily oral pre-exposure prophylaxis during the ECHO trial 
    Beesham, Ivana; Mansoor, Leila E.; Davey, Dvora L. Joseph; Palanee-Phillips, Thesla; Smit, Jennifer; Ahmed, Khatija; Selepe, Pearl; Louw, Cheryl; Singata-Madliki, Mandisa; Kotze, Philip; Heffron, Renee; Parikh, Urvi M.; Wiesner, Lubbe; Rees, Helen; Baeten, Jared M.; Beksinska, Mags (Lippincott Williams and Wilkins, 2022-09)
    BACKGROUND : HIV endpoint–driven clinical trials provide oral pre-exposure prophylaxis (PrEP) as HIV prevention standard of care. We evaluated quantifiable plasma tenofovir among South African women who used oral PrEP ...